Cargando…
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19
The global pandemic of Coronavirus Disease 2019 (COVID-19) has brought the world to a grinding halt. A major cause of concern is the respiratory distress associated mortality attributed to the cytokine storm. Despite myriad rapidly approved clinical trials with repurposed drugs, and time needed to d...
Autores principales: | Lokhande, Amit S., Devarajan, Padma V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678434/ https://www.ncbi.nlm.nih.gov/pubmed/33227285 http://dx.doi.org/10.1016/j.ejphar.2020.173748 |
Ejemplares similares
-
Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?
por: Mahmoud, Dina B., et al.
Publicado: (2020) -
Nitazoxanide and COVID-19: A review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Antiprotozoal Nitazoxanide Derivatives: Synthesis, Bioassays and QSAR Study Combined with Docking for Mechanistic Insight
por: Scior, Thomas, et al.
Publicado: (2015) -
Clinical features and mechanistic insights into drug repurposing for combating COVID-19
por: Asrani, Purva, et al.
Publicado: (2022) -
Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis
por: Rajoli, Rajith K. R., et al.
Publicado: (2020)